CA
GWPH

Claro Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Claro Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-257
Closed -$44K – 1046
2018
Q4 		$44K Buy
+257
New +$33.7K 0.04% 357

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Claro Advisors's GWPH Position: Q1 2019 in Review

Claro Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 257 shares — an estimated $44K sold.

Claro Advisors first reported a position in GWPH in Q4 2018 and held it in 1 quarter. The position peaked at $44K in Q4 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

  • Claro Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Claro Advisors sold 257 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $44K.
  • Claro Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 1 quarter.
  • Claro Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $44K in Q4 2018.
  • 320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.